Catalyst Wire Dossier Catalyst Wire Dossier

V211-007

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V211-007, covering 2017-03-15 to 2017-03-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007) [Phase 2]

See pricing